ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 144 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2021. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $105,000 | +425.0% | 15,641 | +851.4% | 0.00% | +300.0% |
Q3 2021 | $20,000 | -87.5% | 1,644 | -78.3% | 0.00% | -80.0% |
Q2 2021 | $160,000 | +321.1% | 7,577 | +413.7% | 0.01% | +150.0% |
Q4 2020 | $38,000 | +137.5% | 1,475 | +250.4% | 0.00% | 0.0% |
Q3 2020 | $16,000 | -91.7% | 421 | -88.8% | 0.00% | -90.5% |
Q2 2020 | $192,000 | +300.0% | 3,749 | +264.0% | 0.02% | +61.5% |
Q2 2019 | $48,000 | -12.7% | 1,030 | -24.2% | 0.01% | -40.9% |
Q1 2019 | $55,000 | +5400.0% | 1,359 | +6371.4% | 0.02% | – |
Q3 2018 | $1,000 | -97.9% | 21 | -96.8% | 0.00% | -100.0% |
Q1 2018 | $48,000 | – | 664 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |